These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3358296)

  • 1. [The dose-effect relationship in connection with the study of the interaction of chemical carcinogens].
    Katul'skiĭ IuN
    Vopr Onkol; 1988; 34(3):322-30. PubMed ID: 3358296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response problems in carcinogenesis.
    Crump KS
    Biometrics; 1979 Mar; 35(1):157-67. PubMed ID: 497333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculation of carcinogenic potency from long-term animal carcinogenesis experiments.
    Sawyer C; Peto R; Bernstein L; Pike MC
    Biometrics; 1984 Mar; 40(1):27-40. PubMed ID: 6733232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The methodology of an experimental study of the carcinogenicity of jointly acting chemical agents].
    Katul'skiĭ IuN
    Vopr Onkol; 1990; 36(7):785-91. PubMed ID: 2399657
    [No Abstract]   [Full Text] [Related]  

  • 5. [Patterns of the dose-effect dependence of chemical carcinogens].
    Katul'skiĭ IuN
    Vopr Onkol; 1983; 29(6):93-100. PubMed ID: 6868483
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of the biometrician in dosage finding].
    Schneider B
    Arzneimittelforschung; 1977 Feb; 27(2A):257-64. PubMed ID: 577172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mathematical dose-effect models in the study of carcinogenesis].
    Parfenov IuD
    Vopr Onkol; 1986; 32(1):9-22. PubMed ID: 3511610
    [No Abstract]   [Full Text] [Related]  

  • 8. Confidence intervals and test of hypotheses concerning dose response relations inferred from animal carcinogenicity data.
    Crump KS; Guess HA; Deal KL
    Biometrics; 1977 Sep; 33(3):437-51. PubMed ID: 911968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thresholds in chemical carcinogenesis.
    Purchase IF; Auton TR
    Regul Toxicol Pharmacol; 1995 Dec; 22(3):199-205. PubMed ID: 8837843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: dose influences mechanism.
    Counts JL; Goodman JI
    Regul Toxicol Pharmacol; 1995 Jun; 21(3):418-21. PubMed ID: 7480895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear interpolation algorithm for low dose risk assessment of toxic substances.
    Gaylor DW; Kodell RL
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):305-12. PubMed ID: 7217854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of epidemiological observation in elucidating the mechanisms of carcinogenesis.
    Kaldor J
    IARC Sci Publ; 1992; (116):601-8. PubMed ID: 1428102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The methodology for researching the combined action of pharmacological substances by using the mathematical theory of experiments].
    Vladimirov VG; Smirnova SM; Boĭko VN
    Eksp Klin Farmakol; 1993; 56(6):59-62. PubMed ID: 8111303
    [No Abstract]   [Full Text] [Related]  

  • 17. [Application of BMD models in quantitative evaluation of carcinogenic risk].
    Szymczak W
    Med Pr; 1998; 49(6):579-87. PubMed ID: 10204147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer dose-response models.
    Sielken RL; Smith LA
    Dev Toxicol Environ Sci; 1983; 11():173-80. PubMed ID: 6677454
    [No Abstract]   [Full Text] [Related]  

  • 19. Bayesian analysis of a dose-response experiment with serial sacrifices.
    Bratcher TL
    J Environ Pathol Toxicol; 1977; 1(2):287-92. PubMed ID: 553135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.